我們已在上線! 進一步了解
ISEE

IVERIC bio, Inc. Common Stock

已下市

ISEE已於2023年7月10日下市。

 

關於: IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.

員工: 163

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於ISEE的最新新聞文章。

價格圖表採用Lightweight Charts™實作